Clinical Trial Update: Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

View source ↗

Summary

A completed cross-sectional study sponsored by AbbVie assessing the real-world burden of non-segmental vitiligo in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-segmental Vitiligo

Snippet

Sponsor: AbbVie | Conditions: Non-Segmental Vitiligo | Status: COMPLETED